Document is current
Any future updates will be listed below
-
Authors
Murakami, Yusuke https://orcid.org/0000-0002-3761-1732
Hisai, Takahiro
Shimokawa, Sakurako
Fukushima, Masatoshi
Fujiwara, Kohta
Hirata, Akie
Takada, Atsushi
Miyahara, Fuyuka
Nakashima, Naoki
Kobayakawa, Yuko
Arima, Mitsuru
Mawatari, Go
Ishizu, Masataka
Kaida, Tomoko
Miyata, Kazunori
Ikeda, Yasuhiro
Sonoda, Koh-Hei
-
Funding
Funding for this research was provided by:
The Japanese Ministry of Education, Culture, Sports, Science, and Technology (#22H03242)
The Japanese Ministry of Education, Culture, Sports, Science, and Technology (22KK0136)
The Japan Agency for Medical Research and Development, Practical Research Project for Rare/Intractable Diseases (JP23ek0109512h0003)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 13 January 2025
First Online: 5 March 2025
Conflicts of interest
: Y. Murakami, Patents planned, issued or pending (Pitavastatin encapsulated nanoparticle medicine for retinitis pigmentosa), Receipt of equipment, materials, drugs, medical writing, gifts or other services (SENTANÂ Pharma Co. Ltd.); T. Hisai, None; S. Shimokawa, None; M. Fukushima, None; K. Fujiwara, None; A. Hirata, None; A. Takada, None; F. Miyahara, None; N. Nakashima, None; Y. Kobayakawa, None; M. Arima, None; G. Mawatari, None; M. Ishizu, None; T. Kaida, None; K. Miyata, None; Y. Ikeda, None; K. Sonoda, None.
